BenzingaSeptember 8, 2026 at 6:54 AM NYLast Month
RBC Capital Reiterates Outperform on HCA Healthcare, Maintains $435 Price Target
RBC Capital analyst Ben Hendrix reiterates HCA Healthcare (NYSE:HCA) with a Outperform and maintains $435 price target.
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga
